Slide 1 A PARTNERSHIP BETWEEN ACADEMY AND GOVERNMENT FOR IMPROVING PHARMACEUTICAL CARE Prof. Augusto Guerra, PhD & Prof. Francisco Acurcio, PhD Federal University of…

1.Introduction to Post-marketing Drug Safety Surveillance:Pharmacovigilance in FDA/CDER CDR Selena Ready, PharmD, CGP Safety Evaluator Division of Pharmacovigilance Office…

Slide 1 1 EFFECTS OF ANTIINFLAMMATORY AND IMMUNOSUPPRESSIVE MEDICINES ON FERTILITY, PREGNANCY AND LACTATION. DR SULTAN ALMOGAIRIN CONSULTANT RHEUMATOLOGIST Slide 2 2 Effects…

Slide 1 Dr Caroline Sabin, Royal Free Hospital UK-CAB - 13 August 2004- www.i-Base.info Session 5: The design of RCTs of treatments for HIV infection Caroline Sabin Reader…

Slide 1 Fulfilling the Promise of Medicine Together New FDA Safety Reporting Requirements 2010 John McLane, Ph.D. COO & Vice President Clinical and Regulatory Affairs…

Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial Drug Development and…